Swiss National Bank’s Q32 Bio QTTB Stock Holding History

Swiss National Bank’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,672	Closed	-$256K	–	2801
2022 Q1	$256K	Hold	4,672	–	–	﹤0.01%	2667
2021 Q4	$306K	Hold	4,672	–	–	﹤0.01%	2714
2021 Q3	$662K	Hold	4,672	–	–	﹤0.01%	2534
2021 Q2	$611K	Buy	4,672 +1,833	+65%	+$229K	﹤0.01%	2601
2021 Q1	$481K	Hold	2,839	–	–	﹤0.01%	2458
2020 Q4	$577K	Sell	2,839 -294	-9%	-$56.8K	﹤0.01%	2441
2020 Q3	$603K	Buy	3,133 +127	+4%	+$28.5K	﹤0.01%	2320
2020 Q2	$822K	Buy	3,006 +900	+43%	+$240K	﹤0.01%	2211
2020 Q1	$589K	Hold	2,106	–	–	﹤0.01%	2110
2019 Q4	$785K	Buy	2,106 +95	+5%	+$27.2K	﹤0.01%	2264
2019 Q3	$655K	Hold	2,011	–	–	﹤0.01%	2263
2019 Q2	$708K	Buy	2,011 +722	+56%	+$284K	﹤0.01%	2300
2019 Q1	$643K	Hold	1,289	–	–	﹤0.01%	2287
2018 Q4	$519K	Buy	+1,289	New	+$487K	﹤0.01%	2344

Other funds holding QTTB

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Swiss National Bank's QTTB Position: Q2 2022 in Review

Swiss National Bank sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 4,672 shares — an estimated $256K sold.

Swiss National Bank first reported a position in QTTB in Q4 2018 and held it in 14 quarters. The position peaked at $822K in Q2 2020. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

Swiss National Bank reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
Swiss National Bank sold 4,672 Q32 Bio shares in Q2 2022, an estimated $256K.
Swiss National Bank first reported a position in Q32 Bio in Q4 2018 and held it in 14 quarters.
Swiss National Bank's Q32 Bio position peaked at $822K in Q2 2020.
87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.